Electroporation Instruments Market 2022-2030 Developments, Technology Accomplishments, Global Trends, Analysis & Innovative Revolution

Increasing Demand for Electroporation to Transfer Dyes, Ions, Nucleic Acids across Cell Membrane to Aid Market Growth

Technological advancements and R&D activities have played an imperative role in bringing about groundbreaking changes across the healthcare sector. The entry of new technologies has paved the way for cutting-edge medical devices that are increasingly being used to treat an array of medical diseases and conditions. Over the past couple of decades, major developments have occurred across the electroporation instruments market landscape, as market players continue to focus on improving the efficiency and performance of their products. Electroporation is an established physical technique that is primarily used to introduce polar molecules, including DNA into eukaryotic cells via the cell membrane.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111597

Since its discovery in 1982, electroporation is increasingly being used to transfer a range of molecules, including drugs, dyes, ions, and nucleic acids across the membrane of the cell. Over the past two to three decades, considerable progress has been made across the electroporation instruments market, as applications of electroporation continue to expand from DNA transportation to gene transfer, gene therapy, and chemotherapy, among others. Furthermore, with considerable growth in the research and development expenditure, electroporation is extensively being used to deliver chemotherapy drugs and gene electro transfer– factors that are expected to boost the growth of the global electroporation instruments market during the forecast period.

At the back of these factors, the global electroporation instruments market is on the course to surpass ~US$ 244 Mn mark by the end of 2030.

Impressive Approval Rate and Growing Adoption in Developed Regions to Bolster Market Growth

Developed regions, including North America and Europe are expected to provide lucrative growth opportunities to the players involved in the current electroporation instruments market landscape. The advanced healthcare infrastructure coupled with rapid advancements in technology is expected to play an imperative role in boosting the growth of the electroporation instruments market in these regions. Furthermore, the approval rate of electroporation instruments across Europe and North America is comparatively higher than that across the Asia Pacific region. In addition, as electroporation continues to gain considerable adoption across Europe due to the increasing approval for the clinical use of electro chemotherapy, market players are likely to focus on tapping into the opportunities across the European Union. Furthermore, as regulations and guidelines pertaining to the adequate usage of electroporation instruments continue to being published, the demand for electroporation instruments continues to grow.

View full report@ https://qyresearchmedical.com/report/electroporation-instruments-market-product-total-electroporation-system-eukaryotic-electroporation-system-and-microbial-electroporation-system-and-application-bio-medical-research-therapeutic-delivery-and-pr-2020-2030/111597

Progress in Gene Editing Techniques to Propel Market Growth

Advancements in gene editing technologies, including regularly-interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins or transcription activator-like effector nucleases (TALENs) have enabled researchers to curate targeted sequence-specific changes across the DNA– a factor that is expected to increase the adoption of electroporation instruments in the upcoming years. As advancements in gene-editing techniques occur at a consistent pace, the prospects of the electroporation instruments market continue to stare at a bright future. Furthermore, as applications of gene editing techniques continue to expand owing to research and development, the adoption of electroporation instruments is likely to witness a considerable growth. In addition, major advancements in the electroporation instruments and electrodes coupled with the increasing compatibility with cutting-edge gene editing technology are likely to play a key role in the overall development of the global electroporation instruments market.

Furthermore, as electroporation penetrates 3D structures with high levels of efficiency, advanced gene editing techniques are likely to gain further traction in the upcoming decade. Moreover, in the current scenario, players operating in the current electroporation instruments market are increasingly focusing on launching preset starting electroporation parameters for highly common samples, which, in turn, is likely to minimize the degree of optimization for researchers.

Market Growth Likely to Remain Steady amid COVID-19 Pandemic

The impact of the COVID-19 pandemic on the global electroporation instruments market is expected to remain moderate in 2020, as research and development activities are likely to remain unaffected. Furthermore, increasing adoption of the gene editing technology across the healthcare sector worldwide is likely to continue in 2020 due to which, the electroporation instruments market is projected to witness steady growth. As precision medicines are playing an imperative role in assisting researchers and scientists to evaluate the novel coronavirus, the demand for electroporation instruments is likely to grow. In addition, CRISPR-based diagnostics are increasingly being used to accurately diagnose a range of medical diseases, including the novel COVID-19 infection– another factor that is expected to propel the growth of the market for electroporation instruments during the COVID-19 era.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111597/2900

Analysts’ Viewpoint

The global electroporation instruments market is expected to grow at a healthy CAGR of ~6% during the forecast period. The market growth is primarily driven by factors such as advancements in the gene editing and gene testing sphere, research and development activities, increasing awareness pertaining to the benefits of electroporation instruments, and surge in the approval rates for electroporation instruments across developed regions, including North America and Europe. Market players should focus on research and development, and leverage opportunities linked to gene editing technique and testing.

Electroporation Instruments Market: Overview

The global electroporation instruments market for the historical period 2018–2019 and forecast period 2020–2030, development of vaccine delivery systems using electroporation technology is projected to drive the global electroporation instruments market during the forecast period

According to the report, the global electroporation instruments market was valued at ~US$ 126 Mn in 2019 and is projected to reach ~US$ 244 Mn by 2030, expanding at a CAGR of ~6% from 2020 to 2030

Development of Vaccine Delivery System Using Electroporation Technology: Key Driver

Electroporation technique is widely preferred to enhance the uptake of nucleic acid with the DNA in order to generate an immune response against an antigen when the vaccine is delivered through the skin

Rise in prevalence of infectious diseases and other skin disorders is likely to drive the demand for electroporation instruments. Potential of the electrophoresis method in locating the local antigen expression in epidermis offers a significant advantage to patients.

Electroporation technique creates an inflammatory environment and hence, its association with DNA vaccination would result in strong expression of vaccine antigen, thus driving the global electroporation instruments market

Rising Demand for Protein Production Promotes Use of Transfection Technology Methods Leading to Market Expansion

Protein production through the expression of mammalian cells is a significant aspect in the biotechnology industry. Proteins such as erythropoietins and human growth hormones are efficiently utilized as a treatment option for cancers, infectious diseases, and autoimmune diseases.

Most autoimmune diseases and cancer are treated by biotherapeutics, where protein is the primary ingredient for the production of biotherapeutics

Electroporation is considered to be highly preferred process in the delivery of protein to study the expression and development of treatment in the genomic engineering process. This, in turn, is likely to propel the global electroporation instruments market.

Non-specific Transport and Other Damages to Hamper Electroporation Instruments Market

Electroporation methods have few disadvantages compared to other delivery systems

In some cases, non-specific transport of the material can result in an ion imbalance, which could lead to improper cell function and death. Irreversible electroporation could lead to loss of cell homeostasis, widely considered as unconventional mode for cell death.

Electroporation method causes complication and skin edema, as compared to other physical methods

In other chemical methods, instruments are not required, which are highly preferred by some researchers. However, in some instances, electroporation effectiveness is widely influenced by other factors such as cell or tissue type and DNA formulation.

Electroporation Instruments Market: Competition Landscape

This report profiles major players in the global electroporation instruments market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global electroporation instruments market is highly fragmented with the presence of numerous large and small players

Major players operating in the global electroporation instruments market are

  • BEX Co. Ltd.
  • Celetrix LLC
  • Merck KGaA
  • Eppendorf AG
  • Harvard Bioscience Inc. (BTX)
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories
  • MaxCyte Inc.
  • Lonza Group
  • Mirus Bio LLC

Electroporation instruments Market: Key Developments

In January 2018, Harvard Biosciences Inc. acquired Data Sciences International, Inc. worth US$ 71.1 Mn, which is a leading global player offering preclinical products, solutions, systems, and services to pharmaceutical, biotechnology, CROs, research laboratories, and government research institutes

The report on the global electroporation instruments market discussed individual strategies, followed by company profiles of manufacturers of bilirubin analyzers and meters. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global electroporation instruments market.

Key Questions Answered in Electroporation Instruments Market Report

  • What is the scope of growth of companies in the global electroporation instruments market?
  • What will be the Y-o-Y growth of the global electroporation instruments market between 2020 and 2030?
  • What is the influence of changing trends in technologies on the global electroporation instruments market?
  • Will North America continue to be the most profitable market for electroporation instruments providers?
  • Which factors will hamper the growth of the global electroporation instruments market during the forecast period?
  • Which are the leading companies in the global electroporation instruments market?

Electroporation Instruments Market – Segmentation

Product

  • Total Electroporation System
  • Eukaryotic Electroporation System
  • Microbial Electroporation System

Application

  • Bio-Medical Research
  • Transgenic Models
  • Cancer Research
  • Gene and Protein Expression Studies
  • Cell-based Microarrays for Drug Discovery and Development
  • Therapeutic Delivery
  • Biotherapeutics
  • Electro-chemotherapy and Electro-immunotherapy
  • Protein Production

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Electroporation Instruments Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.1.3. Overview

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Global Electroporation Instruments Market Analysis and Forecast, 2018–2030

4.3.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

5.2. Value Chain Analysis

5.3. Technological Advancements

5.4. Health Care Overview

5.5. Porter’s Five Force Analysis

6. Global Electroporation Instruments Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Electroporation Instruments Market Value & Volume Forecast, by Product, 2018–2030

6.3.1. Eukaryotic Electroporation System

6.3.2. Microbial Electroporation System

6.3.3. Total Electroporation System

6.4. Global Electroporation Instruments Market Attractiveness, by Product

7. Global Electroporation Instruments Market Analysis and Forecast, by Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Electroporation Instruments Market Value Forecast, by Application, 2018–2030

7.3.1. Bio-Medical Research

7.3.1.1. Cancer Research

7.3.1.2. Cell based microarrays for drug discovery and development

7.3.1.3. Gene and protein expression studies

7.3.1.4. Transgenic models

7.3.2. Protein Production

7.3.3. Therapeutic Delivery

7.3.3.1. Biotherapeutics

7.3.3.2. Electro-chemotherapy and electro-immunotherapy

7.4. Global Electroporation Instruments Market Attractiveness, by Application

8. Global Electroporation Instruments Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Electroporation Instruments Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Electroporation Instruments Market Attractiveness, by Region

9. North America Electroporation Instruments Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. North America Electroporation Instruments Market Value & Volume Forecast, by Product, 2018–2030

9.2.1. Eukaryotic Electroporation System

9.2.2. Microbial Electroporation System

9.2.3. Total Electroporation System

9.3. North America Electroporation Instruments Market Value Forecast, by Application, 2018–2030

9.3.1. Bio-Medical Research

9.3.1.1. Cancer Research

9.3.1.2. Cell based microarrays for drug discovery and development

9.3.1.3. Gene and protein expression studies

9.3.1.4. Transgenic models

9.3.2. Protein Production

9.3.3. Therapeutic Delivery

9.3.3.1. Biotherapeutics

9.3.3.2. Electro-chemotherapy and electro-immunotherapy

9.4. North America Electroporation Instruments Market Value Forecast, by Country, 2018–2030

9.4.1. U.S.

9.4.2. Canada

9.5. North America Electroporation Instruments Market Attractiveness Analysis

9.5.1. By Product

9.5.2. By Application

9.5.3. By Country

10. Europe Electroporation Instruments Market Analysis and Forecast

10.1. Introduction

10.2. Key Findings

10.3. Europe Electroporation Instruments Market Value & Volume Forecast, by Product, 2018–2030

10.3.1. Eukaryotic Electroporation System

10.3.2. Microbial Electroporation System

10.3.3. Total Electroporation System

10.4. Europe Electroporation Instruments Market Value Forecast, by Application, 2018–2030

10.4.1. Bio-Medical Research

10.4.1.1. Cancer Research

10.4.1.2. Cell based microarrays for drug discovery and development

10.4.1.3. Gene and protein expression studies

10.4.1.4. Transgenic models

10.4.2. Protein Production

10.4.3. Therapeutic Delivery

10.4.3.1. Biotherapeutics

10.4.3.2. Electro-chemotherapy and electro-immunotherapy

10.5. Europe Electroporation Instruments Market Value Forecast, by Country/Sub-region, 2018–2030

10.5.1. Germany

10.5.2. U.K.

10.5.3. France

10.5.4. Spain

10.5.5. Italy

10.5.6. Rest of Europe

10.6. Europe Electroporation Instruments Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Application

10.6.3. By Country/Sub-region

11. Asia Pacific Electroporation Instruments Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Asia Pacific Electroporation Instruments Market Value & Volume Forecast, by Product, 2018–2030

11.2.1. Eukaryotic Electroporation System

11.2.2. Microbial Electroporation System

11.2.3. Total Electroporation System

11.3. Asia Pacific Electroporation Instruments Market Value Forecast, by Application, 2018–2030

11.3.1. Bio-Medical Research

11.3.1.1. Cancer Research

11.3.1.2. Cell based microarrays for drug discovery and development

11.3.1.3. Gene and protein expression studies

11.3.1.4. Transgenic models

11.3.2. Protein Production

11.3.3. Therapeutic Delivery

11.3.3.1. Biotherapeutics

11.3.3.2. Electro-chemotherapy and electro-immunotherapy

11.4. Asia Pacific Electroporation Instruments Market Value Forecast, by Country/Sub-region, 2018–2030

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Electroporation Instruments Market Attractiveness Analysis

11.5.1. By Product

11.5.2. By Application

11.5.3. By Country/Sub-region

12. Latin America Electroporation Instruments Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Latin America Electroporation Instruments Market Value & Volume Forecast, by Product, 2018–2030

12.2.1. Eukaryotic Electroporation System

12.2.2. Microbial Electroporation System

12.2.3. Total Electroporation System

12.3. Latin America Electroporation Instruments Market Value Forecast, by Application, 2018–2030

12.3.1. Bio-Medical Research

12.3.1.1. Cancer Research

12.3.1.2. Cell based microarrays for drug discovery and development

12.3.1.3. Gene and protein expression studies

12.3.1.4. Transgenic models

12.3.2. Protein Production

12.3.3. Therapeutic Delivery

12.3.3.1. Biotherapeutics

12.3.3.2. Electro-chemotherapy and electro-immunotherapy

12.4. Latin America Electroporation Instruments Market Value Forecast, by Country/Sub-region, 2018–2030

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Electroporation Instruments Market Attractiveness Analysis

12.5.1. By Product

12.5.2. By Application

12.5.3. By Country/Sub-region

13. Middle East & Africa Electroporation Instruments Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Middle East & Africa Electroporation Instruments Market Value & Volume Forecast, by Product, 2018–2030

13.2.1. Eukaryotic Electroporation System

13.2.2. Microbial Electroporation System

13.2.3. Total Electroporation System

13.3. Middle East & Africa Electroporation Instruments Market Value Forecast, by Application, 2018–2030

13.3.1. Bio-Medical Research

13.3.1.1. Cancer Research

13.3.1.2. Cell based microarrays for drug discovery and development

13.3.1.3. Gene and protein expression studies

13.3.1.4. Transgenic models

13.3.2. Protein Production

13.3.3. Therapeutic Delivery

13.3.3.1. Biotherapeutics

13.3.3.2. Electro-chemotherapy and electro-immunotherapy

13.4. Middle East & Africa Electroporation Instruments Market Value Forecast, by Country/Sub-region, 2018–2030

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Electroporation Instruments Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By Application

13.5.3. By Country/Sub-region

14. Competition Landscape

14.1. Global Electroporation Instruments Market Analysis, by Top Company Ranking, 2019

14.2. Competitive Business Strategies

14.3. Company Profiles

14.3.1. BEX Co. Ltd.

14.3.1.1. Company Overview

14.3.1.2. Growth Strategies

14.3.1.3. SWOT Analysis

14.3.2. Celetrix LLC

14.3.2.1. Company Overview

14.3.2.2. Growth Strategies

14.3.2.3. SWOT Analysis

14.3.3. Merck KGaA

14.3.3.1. Company Overview

14.3.3.2. Growth Strategies

14.3.3.3. SWOT Analysis

14.3.4. Eppendorf AG

14.3.4.1. Company Overview

14.3.4.2. Growth Strategies

14.3.4.3. SWOT Analysis

14.3.5. Harvard Bioscience Inc. (BTX)

14.3.5.1. Company Overview

14.3.5.2. Growth Strategies

14.3.5.3. SWOT Analysis

14.3.6. Thermo Fisher Scientific, Inc.

14.3.6.1. Company Overview

14.3.6.2. Growth Strategies

14.3.6.3. SWOT Analysis

14.3.7. Bio-Rad Laboratories

14.3.7.1. Company Overview

14.3.7.2. Growth Strategies

14.3.7.3. SWOT Analysis

14.3.8. MaxCyte Inc

14.3.8.1. Company Overview

14.3.8.2. Growth Strategies

14.3.8.3. SWOT Analysis

14.3.9. Lonza Group

14.3.9.1. Company Overview

14.3.9.2. Growth Strategies

14.3.9.3. SWOT Analysis

14.3.10. Mirus Bio LLC

14.3.10.1. Company Overview

14.3.10.2. Growth Strategies

14.3.10.3. SWOT Analysis

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111597/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi